ENORAMA PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.43 SEK | +2.97% |
|
-0.82% | -21.61% |
| 05-22 | Enorama Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-28 | Intervacc's Acting CEO Assumes Role Permanently | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.970 | 4.420 | 3.980 |
| Spread/Res. | -18.18% | -45.02% | -38.94% |
| Spread/Supp. | +4.29% | +12.50% | +7.05% |
| Support | 2.330 | 2.160 | 2.270 |
- Stock Market
- Equities
- ERMA Stock
- Charts Enorama Pharma AB
